THQ HOSPITAL PIND DADAN KHAN
DEPARTMENT OF PHARMACEUTICAL SERVICES
DRUG INFORMATION SERVICES
TABLET COAMOXICLAVE (AMOXICILLIN +CLAVULANIC ACID)
AVAILABLE STRENGTH :500+150 mg
INDICATIONS AND DOSE
1. INFECTIONS DUE TO BETA-LACTAMASE-PRODUCING STRAINS (WHERE AMOXICILLIN
ALONE NOT APPROPRIATE), INCLUDING RESPIRATORY TRACT INFECTIONS, BONE AND
JOINT INFECTIONS, GENITO-URINARY AND ABDOMINAL INFECTIONS, CELLULITIS AND
ANIMAL BITES
▶ BY MOUTH USING TABLETS
Child 12–17 years: 250/125 mg every 8 hours; increased to 500/125 mg every 8 hours, increased
dose used for severe infection
Adult: 250/125 mg every 8 hours; increased to 500/125 mg every 8 hours, increased dose used
for severe infection
▶ BY INTRAVENOUS INJECTION, OR BY INTRAVENOUS INFUSION
Child 1–2 months: 30 mg/kg every 12 hours, intravenous infusion recommended in children less
than 3 months
Child 3 months–17 years: 30 mg/kg every 8 hours (max. per dose 1.2 g every 8 hours)
Adult: 1.2 g every 8 hours
2. SEVERE DENTAL INFECTION WITH SPREADING CELLULITIS | DENTAL INFECTION NOT
RESPONDING TO FIRST-LINE ANTIBACTERIAL
▶ BY MOUTH USING TABLETS
Child 12–17 years: 250/125 mg every 8 hours for 5 days
Adult: 250/125 mg every 8 hours for 5 days
3. SURGICAL PROPHYLAXIS
▶ BY INTRAVENOUS INJECTION, OR BY INTRAVENOUS INFUSION
Adult: 1.2 g, to be administered up to 30 minutes before the procedure, then 1.2 g every 8
hours for up to 2–3 further doses in high-risk procedures
4. ACUTE EXACERBATION OF BRONCHIECTASIS
▶ BY MOUTH USING TABLETS
Child 12–17 years: 250/125 mg 3 times a day for 7–14 days, alternatively 500/125 mg 3 times a
day for 7–14 days
Adult: 500/125 mg 3 times a day for 7–14 days
▶ BY INTRAVENOUS INFUSION, OR BY INTRAVENOUS INJECTION
Child 1–2 months: 30 mg/kg every 12 hours, intravenous infusion is recommended in children
less than 3 months
Child 3 months–17 years: 30 mg/kg every 8 hours (max. per dose 1.2 g every 8 hours)
Adult: 1.2 g every 8 hours
DRUG INFORMATION SERVICES
REFERENCE:BNF 2019-2020
THQ HOSPITAL PIND DADAN KHAN
DEPARTMENT OF PHARMACEUTICAL SERVICES
TABLET COAMOXICLAVE (AMOXICILLIN +CLAVULANIC ACID)
AVAILABLE STRENGTH :500+150 mg
5. ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
▶ BY MOUTH USING TABLETS
Adult: 500/125 mg 3 times a day for 5 days
▶ BY INTRAVENOUS INJECTION, OR BY INTRAVENOUS INFUSION
▶ Adult: 1.2 g every 8 hours
6. ACUTE SINUSITIS
▶ BY MOUTH USING TABLETS
▶ Child 12–17 years: 250/125 mg 3 times a day for 5 days, alternatively 500/125 mg 3 times a
day for 5 days
▶ Adult: 500/125 mg 3 times a day for 5 days
7. ACUTE OTITIS MEDIA
▶ BY MOUTH USING TABLETS
▶ Child 12–17 years: 250/125 mg 3 times a day for 5–7 days, alternatively 500/125 mg 3 times
a day for 5–7 days
Note:
a. In order to encounter antibiotic resistance strict compliance to dose is necessary.
b. The 250 mg and 500 mg tablets of amoxicillin and clavulanic acid contain the same
amount of clavulanic acid. Do not substitute two 250 mg tablets for one 500 mg tablet.
The 250 mg regular tablet and the 250 mg chewable tablet contain different amounts of
clavulanic acid. They also should not be substituted.
Hospital Pharmacist Medical Superintendent
REFERENCE:BNF 2019-2020